FMR LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,092
-99.4%
4,954
-99.3%
0.00%
Q2 2023$5,715,755
-63.5%
681,258
-56.8%
0.00%
-100.0%
Q1 2023$15,665,350
+133.0%
1,577,578
+63.3%
0.00%0.0%
Q4 2022$6,723,889
+19.9%
966,076
-8.0%
0.00%0.0%
Q3 2022$5,609,000
+108.4%
1,050,459
+55.7%
0.00%
Q2 2022$2,692,000
+15735.3%
674,584
+17051.9%
0.00%
Q1 2022$17,0003,933
+3872.7%
0.00%
Q4 2021$0
-100.0%
99
-100.0%
0.00%
-100.0%
Q3 2021$10,554,000
-22.5%
1,202,010
-0.0%
0.00%0.0%
Q2 2021$13,620,000
+50.9%
1,202,096
+58.2%
0.00%0.0%
Q1 2021$9,026,000
+924.5%
759,794
+491.3%
0.00%
Q4 2020$881,000
-26.0%
128,488
-20.0%
0.00%
Q3 2020$1,190,000
-53.4%
160,533
-73.8%
0.00%
Q2 2020$2,553,000
-14.4%
612,133
-49.3%
0.00%
Q1 2020$2,981,000
-61.8%
1,206,733
-10.1%
0.00%
-100.0%
Q4 2019$7,795,000
+10.2%
1,341,633
-0.0%
0.00%0.0%
Q3 2019$7,071,000
-26.0%
1,341,733
-15.8%
0.00%0.0%
Q2 2019$9,560,000
-44.2%
1,593,333
-15.9%
0.00%
-50.0%
Q1 2019$17,118,000
-19.6%
1,895,633
-26.1%
0.00%
-33.3%
Q4 2018$21,284,000
-39.9%
2,564,3330.0%0.00%
-25.0%
Q3 2018$35,388,000
+176.3%
2,564,333
+59.1%
0.00%
+300.0%
Q2 2018$12,810,000
+6.0%
1,611,3110.0%0.00%0.0%
Q1 2018$12,085,000
+10.3%
1,611,3110.0%0.00%0.0%
Q4 2017$10,957,000
-5.6%
1,611,3110.0%0.00%0.0%
Q3 2017$11,601,000
+49.2%
1,611,311
-2.6%
0.00%0.0%
Q2 2017$7,775,000
-8.8%
1,654,311
-3.0%
0.00%0.0%
Q1 2017$8,527,000
-11.3%
1,705,311
-5.1%
0.00%0.0%
Q4 2016$9,618,000
-31.9%
1,797,8110.0%0.00%
-50.0%
Q3 2016$14,113,000
+38.0%
1,797,8110.0%0.00%
+100.0%
Q2 2016$10,230,000
+69.8%
1,797,811
+25.0%
0.00%0.0%
Q1 2016$6,024,000
-38.2%
1,437,8110.0%0.00%0.0%
Q4 2015$9,748,000
+16.3%
1,437,8110.0%0.00%0.0%
Q3 2015$8,382,000
-24.9%
1,437,8110.0%0.00%0.0%
Q2 2015$11,157,000
+28.8%
1,437,811
+72.2%
0.00%0.0%
Q1 2015$8,665,000
+43.8%
834,8110.0%0.00%0.0%
Q4 2014$6,027,000
+20.1%
834,8110.0%0.00%0.0%
Q3 2014$5,017,000
-9.2%
834,8110.0%0.00%0.0%
Q2 2014$5,526,000834,8110.00%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders